Probiotics administration following sleeve gastrectomy surgery: A randomized double-blind trial

Keyphrases

• Laparoscopic Sleeve Gastrectomy 100%
• Sleeve Gastrectomy 100%
• Probiotic Administration 100%
• Double-blind Trial 100%
• Non-alcoholic Fatty Liver Disease (NAFLD) 66%
• Clinical Outcomes 66%
• Quality of Life 66%
• Placebo 66%
• Fibrosis 33%
• C-reactive Protein 33%
• Leptin 33%
• Remission Rate 33%
• Metabolic Parameters 33%
• Bariatric Surgery 33%
• Body Mass Index 33%
• Abdominal Ultrasound 33%
• 12-month Follow-up 33%
• Placebo Groups 33%
• Randomized Placebo-controlled Trial 33%
• Morbid Obesity 33%
• Fat Content 33%
• Liver Fibrosis 33%
• Disease Remission 33%
• Liver Enzymes 33%
• Liver Fat Content 33%
• Microbial Composition 33%
• Fecal Samples 33%
• Inflammatory Parameters 33%
• Alpha Diversity 33%
• Shear Wave Elastography 33%
• Cytokeratin 18 33%
• Microdiversity 33%

Medicine and Dentistry

• Sleeve Gastrectomy 100%
• Probiotics 100%
• Placebo 66%
• Laparoscopic Sleeve Gastrectomy 50%
• Quality of Life 33%
• Fibrosis 33%
• Nonalcoholic Fatty Liver 33%
• Spontaneous Remission 33%
• Fat Content 33%
• Anthropometry 16%
• Body Mass Index 16%
• Arm 16%
• Leptin 16%
• Liver Enzyme 16%
• Bariatric Surgery 16%
• C Reactive Protein 16%
• Shear Wave Elastography 16%
• Keratin 18 16%
• Microflora 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Placebo 100%
• Nonalcoholic Fatty Liver 50%
• Fibrosis 50%
• Remission 50%
• Fatty Liver 25%
• Leptin 25%
• Liver Enzyme 25%
• C Reactive Protein 25%
• Microflora 25%
• Cytokeratin 18 25%